REG - Hammerson PLC - EMTN Programme: publication of Base Prospectus

HammersonAnnouncement

15/04/2025 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250415:nRSO1578Fa&default-theme=true

RNS Number : 1578F  Hammerson PLC  15 April 2025

15 April 2025

Hammerson plc

EMTN Programme: publication of Base Prospectus

Hammerson plc announces that certain legal and regulatory updates and
amendments have been made to the base prospectus (the "Prospectus") relating
to the £5,000,000,000 Euro Medium Term Note Programme under which Hammerson
plc is an issuer. The Prospectus has been approved by the Financial Conduct
Authority and has been published.

A copy of the Prospectus has been submitted to the National Storage Mechanism
and will shortly be available for inspection at and can be downloaded from:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

and

https://www.hammerson.com/investors/debt-investors
(https://www.hammerson.com/investors/debt-investors)

For further information:

Hammerson Investor Contacts

Josh Warren, Director of Strategy, Commercial Finance and Investor Relations

T: +44 (0) 20 7887 1053         E: josh.warren@hammerson.com

 

MHP for Hammerson Media

Ollie Hoare and Charles Hirst

T: +44 (0)20 3128 8100          E: Hammerson@mhpgroup.com

 

DISCLAIMER - INTENDED ADDRESSEES

EU MiFID II professionals/ECPs only/No EEA PRIIPs KID

UK MiFIR professionals/ECPs only/No UK PRIIPs KID

This announcement does not constitute or form part of an offer to sell or the
solicitation of an offer to subscribe for or otherwise acquire any securities.

In particular, neither this announcement nor the Prospectus shall constitute
an offer to sell or the solicitation of an offer to buy securities in the
United States or in any other jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration, exemption from registration
or qualification under the securities law of any such jurisdiction.

The securities referred to herein have not been and will not be registered
under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or
with any securities regulatory authority of any State or other jurisdiction of
the United States, and are subject to Unites States tax law requirements.
Subject to certain exceptions, the securities referred to herein may not be
offered, sold or delivered in the United States or to, or for the account or
benefit of, U.S. persons (as defined in Regulation S under the Securities
Act). The Prospectus may not be accessed from, or transmitted in or into, the
United States. Accordingly, these securities may not be offered, sold or
delivered in the United States.

Please note that the information contained in the Prospectus may be addressed
to and/or targeted at persons who are residents of particular countries
(specified in the Prospectus) only and is not intended for use and should not
be relied upon by any person outside these countries and/or to whom the offer
contained in the Prospectus is not addressed. Prior to relying on the
information contained in the Prospectus, you must ascertain from the
Prospectus whether or not you are part of the intended addressees of the
information contained therein.

Your right to access this service is conditional upon complying with the above
requirements.

 

The announcement above has also been released on the SENS system of the
Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIEASLSFFNSEFA